Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • AXON vs GSK✓SelectedUSD · GSKAXON vs GSK performance historyLatest closeAs of-2.85%11/16
Stock and ETF performance explorer

AXON vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-43.6%
GSK return
+9.7%
Excess return
-53.3%
Maximum drawdown
-53.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.9%-0.1%-2.8%-2.8%
7D+1.1%-1.3%+2.4%+1.1%
30D-21.5%+2.7%-24.2%-21.5%
3M-50.0%+2.7%-52.7%-49.8%
6M-21.8%+3.3%-25.1%-21.3%
YTD-46.0%+6.5%-52.5%-48.3%
All-43.6%+9.7%-53.3%-47.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling